Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin�) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

�erefhano�lu, Song�l; Koca, Ebru; Goker, Hakan; Haznedaro�lu, �brahim Celalettin; �etiner, Deniz; Say�nalp, Nilg�n; B�y�ka��k, Yahya; �zcebe, Osman �lhami

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin�) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas [Turk J Hematol]

Turk J Hematol. 2008; 25(4): 207-208

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin�) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

Song�l �erefhano�lu, Ebru Koca, Hakan Goker, �brahim Celalettin Haznedaro�lu, Deniz �etiner, Nilg�n Say�nalp, Yahya B�y�ka��k, Osman �lhami �zcebe
Department Of Internal Medicine, Division Of Hematology, Hacettepe University School Of Medicine, Ankara, Turkey

Keywords: Ibritumomab Tiuxetan Radioimmunotherapy, NHL

Di�er lenfomalardan transforme olmu� relaps/refrakter dif�z b�y�k B h�creli lenfomada �l�mc�l yan etkisi ile yttrium-90(90Y)-ibritumomab tiuxetan radyoimmunoterapi (Zevalin�)`nin ba�ar�s�zl��

Song�l �erefhano�lu, Ebru Koca, Hakan Goker, �brahim Celalettin Haznedaro�lu, Deniz �etiner, Nilg�n Say�nalp, Yahya B�y�ka��k, Osman �lhami �zcebe. Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin�) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas. Turk J Hematol. 2008; 25(4): 207-208

Corresponding Author: Song�l �erefhano�lu, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin�) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas

Di�er lenfomalardan transforme olmu� relaps/refrakter dif�z b�y�k B h�creli lenfomada �l�mc�l yan etkisi ile yttrium-90(90Y)-ibritumomab tiuxetan radyoimmunoterapi (Zevalin�)`nin ba�ar�s�zl���

Di�er lenfomalardan transforme olmu� relaps/refrakter dif�z b�y�k B h�creli lenfomada �l�mc�l yan etkisi ile yttrium-90(90Y)-ibritumomab tiuxetan radyoimmunoterapi (Zevalin�)`nin ba�ar�s�zl��